Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : PCES - paid $4.75 Million by 3M Corp!!! -- Ignore unavailable to you. Want to Upgrade?

To: Katie Kommando who wrote (452)	11/9/1999 6:20:00 AM
From: jdcpa	Respond to of 523

It would be very beneficial for John Pappajohn to complete the merger before the end of this year to take advantage of the tax loss carryforwards in 1999 for one of his profitable private companies.

To: Katie Kommando who wrote (452)	11/9/1999 2:01:00 PM
From: Scottey	Respond to of 523

Thank you Katie, Come onnn Pappa! Scottey

To: Katie Kommando who wrote (452)	11/10/1999 8:27:00 PM
From: Scottey	Read Replies (1) \| Respond to of 523

Just thought I would bring it over here. Scottey Monday November 8, 11:18 am Eastern Time Company Press Release IBM Launches Solution to Handle Massive Data Requirements of Life Sciences Industry NetGenics, Inc. to Partner in Deployment WHITE PLAINS, N.Y.--(BW HealthWire)--Nov. 8, 1999--IBM announced today the launch of DiscoveryLink(TM), a solution aimed at dramatically improving product cycle time while lowering development costs for pharmaceutical, biotechnology and agriscience companies. DiscoveryLink, the first solution announced by IBM's newly formed life sciences organization, is a combination of innovative middleware and integration services. IBM's life sciences organization brings together all of IBM's resources, from commercial products to industry knowledge and research, to develop solutions for the life sciences market. IBM will team with NetGenics, Inc., of Cleveland, Ohio, in the deployment of the DiscoveryLink solution. ''Extracting information from multiple data sources used in the research and development of new drugs, gene therapies and plants has caused a critical bottleneck in the life sciences industry,'' said Daniel P. McCurdy, vice president, IBM life sciences. ''By combining our expertise in database and IT infrastructure with NetGenics' superior knowledge of industry applications, we can deliver a solution that we expect will dramatically impact the industry's productivity.'' IBM's DiscoveryLink solution will create a ''virtual database'' by permitting data to be accessed by an application program as if they were in a single database, and in a single format, even though they remain highly heterogeneous in format and highly decentralized. ''The IBM solution will address a core issue in life science research and development, which is the ability to perform complex queries -- queries not even possible today -- across heterogeneous data sources,'' said Manuel J. Glynias, president and CEO of NetGenics, Inc. ''We expect to add value to the DiscoveryLink implementation by applying our knowledge of and expertise in the life sciences industry to the deployment of DiscoveryLink.'' NetGenics will serve as a subcontractor to IBM in the deployment of the DiscoveryLink solution. After completion of testing, DiscoveryLink will be generally available to life sciences customers. Initial installation of DiscoveryLink is expected in coming weeks and will be generally available to the life sciences market in the first quarter 2000. About IBM IBM is the leading information technology company with a proven track record in developing large-scale solutions for major companies around the globe. IBM's new life sciences organization is particularly focused on information and knowledge management -- a strong area of expertise for IBM and a major focus for life sciences companies. About NetGenics NetGenics, Inc., is a privately held company that develops and deploys tailored bioinformatics solutions for the life science market. The company builds integrated computing solutions based on its SYNERGY(TM) software framework and complemented by its SYNERGY-based domain applications and consulting services. NetGenics was established in June 1996 and is headquartered in Cleveland, OH. -------------------------------------------------------------------------------- Contact: NetGenics, Inc. Jan Weaver, 216/861-4007 jweaver@netgenics.com or IBM Global Healthcare Dana Benton-Newell, 914/642-4880 dbnewell@us.ibm.com -------------------------------------------------------------------------------- Related News Categories: biotech, computers, health care, medical/pharmaceutical, software